|
ARL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.714800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.634400E-01 |
| Normal-vs-Stage2 |
6.475600E-01 |
| Normal-vs-Stage3 |
2.019800E-02 |
| Normal-vs-Stage4 |
3.229200E-01 |
| Stage1-vs-Stage2 |
5.785600E-01 |
| Stage1-vs-Stage3 |
4.416600E-03 |
| Stage1-vs-Stage4 |
1.911050E-01 |
| Stage2-vs-Stage3 |
1.262430E-01 |
| Stage2-vs-Stage4 |
4.409000E-01 |
| Stage3-vs-Stage4 |
6.522200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.719400E-01 |
| Normal-vs-AfricanAmerican |
1.147450E-01 |
| Normal-vs-Asian |
4.793600E-01 |
| Caucasian-vs-AfricanAmerican |
2.142600E-01 |
| Caucasian-vs-Asian |
5.043600E-01 |
| AfricanAmerican-vs-Asian |
8.314400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.514800E-01 |
| Normal-vs-Female |
5.821100E-03 |
| Male-vs-Female |
1.797320E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.007600E-01 |
| Normal-vs-Extreme_Weight |
5.051400E-01 |
| Normal-vs-Obese |
1.082950E-01 |
| Normal-vs-Extreme_Obese |
3.306000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.060200E-01 |
| Normal_Weight-vs-Obese |
3.602200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.991600E-01 |
| Extreme_Weight-vs-Obese |
4.717500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.166800E-01 |
| Obese-vs-Extreme_Obese |
1.334820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.494100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.177600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.588600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.449600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.334800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.585800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.113800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.766100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.929600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.319000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.025400E-01 |
| Normal-VS-Type2 PRCC |
4.596600E-01 |
| Normal-VS-KIRP CIMP |
1.638600E-01 |
| Normal-VS-Unclassified PRCC |
8.180100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.357800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.463390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.326500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.693800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.333000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.736200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.649600E-01 |
| Normal-vs-N1 |
2.686100E-02 |
| Normal-vs-N2 |
3.801500E-02 |
| N0-vs-N1 |
4.101600E-02 |
| N0-vs-N2 |
4.058000E-01 |
| N1-vs-N2 |
6.870200E-01 |
|
|
